Transformative Psychopharmacology: the Case of 5-Methoxy-N,N-Dimethyltryptamine
Jan M Keppel Hesselink | International Journal of Psychotherapy Practice and Research | 2 January 2019
DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens
Lakstygal, A., Kolesnikova, T., Khatsko, S., Zabegalov, K., Volgin, A., Demin, K., & Kalueff, A. | ACS chemical neuroscience | 19 December 2018
Pharmacokinetic And Pharmacodynamic Aspects Of Peyote And Mescaline: Clinical And Forensic Repercussions
Dinis-Oliveira, R. J., Pereira, C. L., & Da Silva, D. D | Current molecular pharmacology | 10 October 2018
Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions
Riva-Posse, P., Reiff, C. M., Edwards, J. A., Job, G. P., Galendez, G. C., Garlow, S. J., ... & McDonald, W. M. | Journal of affective disorders | 19 July 2018
Cardiac arrest after ibogaine intoxication
Steinberg, C., & Deyell, M. W | Journal of arrhythmia | 12 June 2018
Key interindividual determinants in MDMA pharmacodynamics
Papaseit, E., Torrens, M., Pérez-Mañá, C., Muga, R., & Farré, M. | Expert opinion on drug metabolism & toxicology | 14 February 2018
Evaluating the abuse potential of psychedelic drugs for medical use in humans
Heal, D. J., Gosden, J., & Smith, S. L. | Neuropharmacology | 7 February 2018
Is LSD toxic?
Nichols, D. E., & Grob, C. S. | Forensic science international | 2 February 2018
Psychedelic Drugs in Biomedicine
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. | Trends in Pharmacological Sciences | 22 September 2017
First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects
Boxler, M. I., Liechti, M. E., Schmid, Y., Kraemer, T., & Steuer, A. E. | Journal of proteome research | 1 September 2017
MDA, MDMA and other mescaline-like substances in the US military’s search for a truth drug (1940s to 1960s)
Passie, T., & Benzenhöfer, U. | Drug testing and analysis | 29 August 2017
Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs
Hassan, Z., Bosch, O. G., Singh, D., Narayanan, S., Kasinather, B. V., Seifritz, E., ... & Müller, C. P. | Frontiers in psychiatry | 18 August 2017
Mushroom-Derived Indole Alkaloids
Homer, J. A., & Sperry, J. | Journal of Natural Products | 19 July 2017
First time view on human metabolome changes after a single intake of 3,4 methylenedioxymethamphetamine (MDMA) in healthy placebo-controlled subjects
Boxler, M. I., Liechti, M. E., Schmid, Y., Kraemer, T., & Steuer, A. E. | Journal of Proteome Research | 19 July 2017
Isolated non-cardiogenic pulmonary edema – A rare complication of MDMA toxicity
Haaland, A., Warman, E., Pushkar, I., Likourezos, A., & Friedman, M. S. | The American journal of emergency medicine | 27 June 2017
A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum
Li, S., Cheng, X., & Wang, C. | Journal of Ethnopharmacology | 5 May 2017
Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults
Brown, R. T., Nicholas, C. R., Cozzi, N. V., Gassman, M. C., Cooper, K. M., Muller, D., ... & Hutson, P. R. | Clinical Pharmacokinetics | 28 March 2017
LSD instead of 25I-NBOMe: The revival of LSD? A case report
Bodeau, S., Bennis, Y., Régnaut, O., Fabresse, N., Richeval, C., Humbert, L., ... & Lemaire-Hurtel, A. S. | Toxicologie Analytique et Clinique | 27 February 2017
Toxicokinetics of ibogaine and noribogaine in a patient with prolonged multiple cardiac arrhythmias after ingestion of internet purchased ibogaine
Henstra, M., Wong, L., Chahbouni, A., Swart, N., Allaart, C., & Sombogaard, F. | Clinical Toxicology | 9 February 2017
Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance
Dinis-Oliveira, R. J. | Drug Metabolism Reviews | 31 January 2017
Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects
Vizeli, P., Schmid, Y., Prestin, K., zu Schwabedissen, H. E. M., & Liechti, M. E. | European Neuropsychopharmacology | 20 January 2017
Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens
Halberstadt, A. L. | Current Topics in Behavioral Neurosciences | 18 January 2017
Hyperthermia Severely Affects the Vascular Effects of MDMA and Metabolites in the Human Internal Mammary Artery In Vitro
Fonseca, D. A., Guerra, A. F., Carvalho, F., Fernandes, E., Ferreira, L. M., Branco, P. S., ... & Cotrim, M. D. | Cardiovascular Toxicology | 13 January 2017
Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015
Heise, C. W., & Brooks, D. E. | Journal of medical toxicology | 28 November 2016
A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4 Methylendioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction
Darracq, M. A., Thornton, S. L., Minns, A. B., & Gerona, R. R. | Journal of Psychoactive Drugs | 16 September 2016